Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment

Eur J Surg Oncol. 2024 Dec;50(12):108653. doi: 10.1016/j.ejso.2024.108653. Epub 2024 Sep 7.
No abstract available

Publication types

  • Letter